CA-125 IS AN EXCRETORY PRODUCT OF HUMAN ENDOMETRIAL GLANDS

被引:32
|
作者
WEINTRAUB, J
BISCHOF, P
TSENG, L
REDARD, M
VASSILAKOS, P
机构
[1] UNIV GENEVA,DEPT OBSTET & GYNECOL,CH-1211 GENEVA 4,SWITZERLAND
[2] SUNY STONY BROOK,DEPT OBSTET & GYNECOL,STONY BROOK,NY 11794
关键词
D O I
10.1095/biolreprod42.4.721
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
The present investigation was undertaken to study the cellular localization and kinetics of synthesis of CA 125 in the endometrium. CA 125 was localized by immunohistochemistry to the infranuclear region of epithelial cells during the proliferative phase and to the apical luminal border during the secretory phase. In gestational endometrium, both the cytoplasm and the apical luminal border of epithelial cells were intensely positive. No staining was seen in endometrial stromal cells during the normal cycle or in decidualized endometria. Results obtained from in vitro cultures of separated glandular and stromal cells were similar to those obtained by immunohistochemistry. That is epithelial cells released between 5 and 25 times more CA 125 into the culture medium than did stromal cells. The release of CA 125 was highest in epithelial and stromal cells obtained during the early secretory phase. CA 125 concentrations were markedly elevated in endometrial aspirations obtained during the secretory phase or in endometria with crumbling stroma compared to plasma levels. Plasma levels of CA 125 were slightly elevated during menses. These results suggest that CA 125 is an exocrine product of endometrial epithelial cells. Plasma levels of CA 125 may be of endometrial origin only when the membrane barriers, which normally prevent its entry into the circulation, are damaged.
引用
收藏
页码:721 / 726
页数:6
相关论文
共 50 条
  • [31] CA-125 IN PATIENTS WITH ENDOMETRIOSIS
    BARBIERI, RL
    FERTILITY AND STERILITY, 1986, 45 (06) : 767 - 769
  • [32] Deceptively High CA-125
    Beneru, D.
    Girgis, M.
    Santiagu, S.
    AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY, 2021, 61 : 43 - 44
  • [33] CA-125 IN GYNECOLOGICAL MALIGNANCIES
    MEIER, W
    STIEBER, P
    FATEHMOGHADAM, A
    EIERMANN, W
    HEPP, H
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1987, 23 (06): : 713 - 717
  • [34] CA-125 IN GYNECOLOGIC PRACTICE
    MALKASIAN, GD
    PODRATZ, KC
    STANHOPE, CR
    RITTS, RE
    ZURAWSKI, VR
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1986, 155 (03) : 515 - 518
  • [35] CA-125 and heart failure
    Ege, Meltem Refiker
    Zorlu, Ali
    Yilmaz, Mehmet Birhan
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2011, 147 (03) : 453 - 454
  • [36] CA-125 in urothelial carcinomas
    Lisle, Allison
    Kaplan, Paul
    Loy, Timothy
    MODERN PATHOLOGY, 2006, 19 : 84 - 84
  • [37] THE PROZONE PHENOMENON OF CA-125
    MULLERHAGEN, S
    HOFFMANN, L
    NEPPERT, J
    ARZTLICHE LABORATORIUM, 1989, 35 (08): : 177 - 182
  • [38] CA-125 immunostaining in mesotheliomas
    Moldavsky, M
    Stayerman, C
    Turani, H
    ACTA CYTOLOGICA, 1997, 41 (04) : 1243 - 1244
  • [39] CA-125 IN THE MANAGEMENT OF ENDOMETRIOSIS
    KONINCKX, PR
    MUYLDERMANS, M
    MEULEMAN, C
    CORNILLIE, FJ
    EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 1993, 49 (1-2): : 109 - 113
  • [40] SERUM CA-125 LEVELS IN PATIENTS WITH ENDOMETRIOSIS - CHANGES IN CA-125 LEVELS DURING MENSTRUATION
    MASAHASHI, T
    MATSUZAWA, K
    OHSAWA, M
    NARITA, O
    ASAI, T
    ISHIHARA, M
    OBSTETRICS AND GYNECOLOGY, 1988, 72 (03): : 328 - 331